FGLIFE Business Summary

Farglory Life Insurance Co., Ltd. (5859.TWO) operates as a prominent mid-tier life insurance provider in Taiwan, generating revenue primarily through insurance premiums and investment returns from its diversified asset portfolio. The company’s business model is segmented into personal life, health, accident, and annuity insurance, alongside a specialized portfolio of investment-linked products. As of 2026, Farglory Life maintains a strategic focus on high-margin health and traditional life products to optimize its capital adequacy and solvency ratios ahead of full IFRS 17 and ICS 2.0 regulatory integration. Within the competitive landscape, it maintains a market share of approximately 2%, ranking as a top-10 domestic insurer by assets; it trails major financial conglomerates like Fubon Life, Cathay Life, and Shin Kong Life, while competing directly with independent peers such as Mercuries Life Insurance for dominance in the agency and bancassurance channels. The company is led by Chairman Meng Jia-ren, a veteran actuary and former General Manager of Mercuries Life Insurance, who holds an actuarial master’s from Temple University and an EMBA from National Taiwan University. Supporting him is General Manager (CEO) Zhao Xue-xin, who has spearheaded the firm’s operational expansion since 2018, and CFO Po Yang Chang, who oversees financial reporting and capital management. Farglory Life is a core subsidiary of the Farglory Group, originally founded by Chao Teng-hsiung; the Group remains the controlling shareholder through investment vehicles including Farglory International Investment and Farglory Land Development. The board is further composed of industry experts and independent directors such as Chen Hong-lin and Yeh Chi-chou, providing a governance framework focused on long-term sustainability and risk-adjusted returns in the evolving Asian financial sector.